Lazard Asset Management LLC Vertex Pharmaceuticals Inc Transaction History

Lazard Asset Management LLC

  • $72.9 Billion
  • Q2 2024

A detailed history of Lazard Asset Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Lazard Asset Management LLC holds 122,456 shares of VRTX stock, worth $58.1 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
122,456
Previous 123,883 1.15%
Holding current value
$58.1 Million
Previous $51.8 Million 10.84%
% of portfolio
0.08%
Previous 0.07%

Shares

38 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$392.81 - $485.53 $560,539 - $692,851
-1,427 Reduced 1.15%
122,456 $57.4 Million
Q1 2024

May 14, 2024
BUY
$407.69 - $446.08 $1.67 Million - $1.83 Million
4,094 Added 3.42%
123,883 $51.8 Million
Q4 2023

Feb 14, 2024
BUY
$343.0 - $410.68 $285,719 - $342,096
833 Added 0.7%
119,789 $48.7 Million
Q3 2023

Nov 14, 2023
SELL
$338.18 - $362.46 $257,016 - $275,469
-760 Reduced 0.63%
118,956 $41.4 Million
Q2 2023

Aug 14, 2023
SELL
$314.42 - $351.91 $2.46 Million - $2.75 Million
-7,814 Reduced 6.13%
119,716 $42.1 Million
Q1 2023

May 15, 2023
SELL
$283.23 - $323.1 $4.22 Million - $4.82 Million
-14,911 Reduced 10.47%
127,530 $40.2 Million
Q4 2022

Feb 14, 2023
SELL
$285.76 - $321.48 $138 Million - $155 Million
-481,400 Reduced 77.17%
142,441 $41.1 Million
Q3 2022

Nov 14, 2022
SELL
$273.83 - $305.53 $65.7 Million - $73.3 Million
-240,065 Reduced 27.79%
623,841 $181 Million
Q2 2022

Aug 09, 2022
SELL
$234.96 - $292.55 $7.97 Million - $9.93 Million
-33,936 Reduced 3.78%
863,906 $243 Million
Q1 2022

May 13, 2022
SELL
$221.42 - $260.97 $3.96 Million - $4.67 Million
-17,878 Reduced 1.95%
897,842 $234 Million
Q4 2021

Feb 09, 2022
BUY
$177.01 - $223.45 $133 Million - $168 Million
749,784 Added 451.85%
915,720 $201 Million
Q3 2021

Nov 15, 2021
BUY
$181.39 - $202.99 $4.39 Million - $4.91 Million
24,195 Added 17.07%
165,936 $30.1 Million
Q2 2021

Aug 12, 2021
BUY
$187.49 - $221.1 $4.85 Million - $5.72 Million
25,856 Added 22.31%
141,741 $28.6 Million
Q1 2021

May 14, 2021
SELL
$207.02 - $241.31 $3.36 Million - $3.92 Million
-16,224 Reduced 12.28%
115,885 $24.9 Million
Q4 2020

Feb 11, 2021
SELL
$207.01 - $276.09 $15.3 Million - $20.5 Million
-74,073 Reduced 35.93%
132,109 $31.2 Million
Q3 2020

Nov 13, 2020
BUY
$255.65 - $303.1 $1.52 Million - $1.81 Million
5,959 Added 2.98%
206,182 $56.1 Million
Q2 2020

Aug 13, 2020
BUY
$225.48 - $295.8 $31.9 Million - $41.9 Million
141,600 Added 241.54%
200,223 $58.1 Million
Q1 2020

May 14, 2020
BUY
$199.77 - $247.81 $652,049 - $808,851
3,264 Added 5.9%
58,623 $13.9 Million
Q4 2019

Feb 13, 2020
BUY
$166.71 - $223.91 $171,211 - $229,955
1,027 Added 1.89%
55,359 $12.1 Million
Q3 2019

Nov 14, 2019
SELL
$166.23 - $187.09 $4.02 Million - $4.53 Million
-24,198 Reduced 30.81%
54,332 $9.2 Million
Q2 2019

Aug 14, 2019
SELL
$164.61 - $190.37 $1.27 Million - $1.47 Million
-7,697 Reduced 8.93%
78,530 $14.4 Million
Q1 2019

May 13, 2019
BUY
$163.73 - $194.7 $8.71 Million - $10.4 Million
53,177 Added 160.9%
86,227 $15.9 Million
Q4 2018

Feb 13, 2019
SELL
$151.91 - $192.21 $901,889 - $1.14 Million
-5,937 Reduced 15.23%
33,050 $5.48 Million
Q3 2018

Nov 13, 2018
BUY
$167.73 - $192.74 $1.22 Million - $1.4 Million
7,252 Added 22.85%
38,987 $7.51 Million
Q2 2018

Aug 13, 2018
SELL
$145.72 - $169.96 $18.6 Million - $21.7 Million
-127,772 Reduced 80.1%
31,735 $5.39 Million
Q1 2018

May 14, 2018
SELL
$151.6 - $177.13 $2.2 Million - $2.56 Million
-14,479 Reduced 8.32%
159,507 $26 Million
Q4 2017

Feb 13, 2018
BUY
$137.28 - $155.55 $77,425 - $87,730
564 Added 0.33%
173,986 $26.1 Million
Q3 2017

Nov 13, 2017
SELL
$148.13 - $162.24 $4.11 Million - $4.5 Million
-27,745 Reduced 13.79%
173,422 $26.4 Million
Q2 2017

Aug 19, 2019
SELL
N/A
-254,906 Reduced 55.89%
201,167 $25.9 Million
Q1 2017

Aug 13, 2019
SELL
N/A
-269,331 Reduced 37.13%
456,073 $49.9 Million
Q4 2016

Jul 30, 2019
SELL
N/A
-472,069 Reduced 39.42%
725,404 $53.4 Million
Q3 2016

Aug 07, 2019
SELL
N/A
-68,285 Reduced 5.39%
1,197,473 $104 Million
Q2 2016

Jul 29, 2019
BUY
N/A
283,415 Added 28.85%
1,265,758 $109 Million
Q1 2016

Jul 25, 2019
BUY
N/A
196,933 Added 25.07%
982,343 $78.1 Million
Q4 2015

Jul 24, 2019
SELL
N/A
-462,435 Reduced 37.06%
785,410 $98.8 Million
Q3 2015

Jul 15, 2019
SELL
N/A
-683,511 Reduced 35.39%
1,247,845 $130 Million
Q2 2015

Jul 08, 2019
SELL
N/A
-403,603 Reduced 17.29%
1,931,356 $238 Million
Q4 2014

Aug 29, 2019
BUY
N/A
2,334,959
2,334,959 $277 Million

Others Institutions Holding VRTX

# of Institutions
1,707
Shares Held
226M
Call Options Held
1.2M
Put Options Held
1.59M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $122B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email